{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Hereditary haemorrhagic telangiectasia",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_aspirin",
          "name": "Aspirin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_nsaids",
          "name": "NSAIDs"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_anticoagulants",
          "name": "Anticoagulants"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_clopidogrel",
          "name": "Clopidogrel"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_warfarin",
          "name": "Warfarin"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_enoxaparin",
          "name": "Enoxaparin"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_dabigatran",
          "name": "Dabigatran"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_rivaroxaban",
          "name": "Rivaroxaban"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_fondaparinux",
          "name": "Fondaparinux"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_thrombolytics",
          "name": "Thrombolytics"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_heparin",
          "name": "Heparin"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_aspirin",
          "type": "Drug",
          "label": "Aspirin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_nsaids",
          "type": "Drug",
          "label": "NSAIDs",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_anticoagulants",
          "type": "Drug",
          "label": "Anticoagulants",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_clopidogrel",
          "type": "Drug",
          "label": "Clopidogrel",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_warfarin",
          "type": "Drug",
          "label": "Warfarin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_enoxaparin",
          "type": "Drug",
          "label": "Enoxaparin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dabigatran",
          "type": "Drug",
          "label": "Dabigatran",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rivaroxaban",
          "type": "Drug",
          "label": "Rivaroxaban",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_fondaparinux",
          "type": "Drug",
          "label": "Fondaparinux",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thrombolytics",
          "type": "Drug",
          "label": "Thrombolytics",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_heparin",
          "type": "Drug",
          "label": "Heparin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_hereditary_hemorrhagic_telangiectasia",
          "type": "Disease",
          "label": "Hereditary haemorrhagic telangiectasia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "mechanism_contraindications",
          "type": "Claim",
          "label": "Contraindications for Hereditary haemorrhagic telangiectasia",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_aspirin",
          "target": "disease_hereditary_hemorrhagic_telangiectasia",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Aspirin 可增加出血风险，常见于相关文献"
        },
        {
          "source": "drug_nsaids",
          "target": "disease_hereditary_hemorrhagic_telangiectasia",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "NSAIDs 与出血风险相关"
        },
        {
          "source": "drug_anticoagulants",
          "target": "disease_hereditary_hemorrhagic_telangiectasia",
          "relation": "causes",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "抗凝剂增加出血风险"
        },
        {
          "source": "drug_clopidogrel",
          "target": "disease_hereditary_hemorrhagic_telangiectasia",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Clopidogrel 可导致出血事件"
        },
        {
          "source": "drug_warfarin",
          "target": "disease_hereditary_hemorrhagic_telangiectasia",
          "relation": "causes",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Warfarin 具有较高出血风险"
        },
        {
          "source": "drug_enoxaparin",
          "target": "disease_hereditary_hemorrhagic_telangiectasia",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Enoxaparin 可能导致内出血"
        },
        {
          "source": "drug_dabigatran",
          "target": "disease_hereditary_hemorrhagic_telangiectasia",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Dabigatran 对出血风险有一定影响"
        },
        {
          "source": "drug_rivaroxaban",
          "target": "disease_hereditary_hemorrhagic_telangiectasia",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Rivaroxaban 可能导致出血"
        },
        {
          "source": "drug_fondaparinux",
          "target": "disease_hereditary_hemorrhagic_telangiectasia",
          "relation": "causes",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Fondaparinux 与出血风险有关"
        },
        {
          "source": "drug_thrombolytics",
          "target": "disease_hereditary_hemorrhagic_telangiectasia",
          "relation": "causes",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "溶栓药物可能加剧出血"
        },
        {
          "source": "drug_heparin",
          "target": "disease_hereditary_hemorrhagic_telangiectasia",
          "relation": "causes",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Heparin 前列腺素合成与出血风险相关"
        },
        {
          "source": "disease_hereditary_hemorrhagic_telangiectasia",
          "target": "mechanism_contraindications",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "支持该病的药物禁忌"
        }
      ]
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "众多药物可能在遗传性出血性毛细血管扩张症中有禁忌使用的风险",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "上述所有药物在基于文献的基础上被认为在该疾病中具有潜在的禁忌症"
    ],
    "uncertainties": [],
    "next_focus_for_pi": [
      "是否需要收集更多文献来支持这些禁忌症的确立"
    ]
  }
}